drugset / Trial / NCT00151450

Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder

NCT00151450 ↗

Phase 3 Completed 390 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to compare pregabalin to Venlafaxine XR and placebo in the treatment of generalized anxiety disorder.

Timeline

Start
2005-03
Primary completion
—
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 300 mg —
Subject Pregabalin Small molecule 600 mg —
Subject Venlafaxine XR Unknown 75 mg —
Subject Venlafaxine XR Unknown 225 mg —

Indications